Taking the Temperature on Vaccines

President Trump continues to predict we will have a COVID vaccine in October, driving a fever pitch of reactions among the public and private industry.

Despite this optimistic forecast, seven-in-ten Americans doubt we will have a vaccine before the end of the year and eight-in-ten worry the president is influencing the vaccine approval process for political points.

As Americans worry politics are taking precedence over science, they are looking to other sources for reliable information about COVID vaccines.

They trust frontline workers most, including doctors, nurses, and nationally recognized health systems.

Fewer trust the CDC, the FDA and drug companies, while trust in the White House depends on personal politics. 71% of Republicans trust information from the White House and President Trump compared to just 21% of Democrats.

The pharmaceutical industry is looking to restore confidence in the vaccine development process as the FDA faces growing criticism.

Nine pharmaceutical companies that currently have a coronavirus vaccine in clinical trials issued a joint pledge to complete Phase III clinical trials to ensure safety and efficacy before submitting vaccines for approval or emergency use authorization.

Still, one-third of Americans say they will not get a coronavirus vaccine as soon it becomes available. Among 27 countries surveyed, the U.S. ranks among the top ten countries where vaccine skepticism is highest.